Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases - 15/01/12
, Elisenda Miró c, Macarena Villar a, Alicia Coelho d, Mónica Gozalo e, Nuria Borrell f, Germán Bou g, M. Carmen Conejo h, Virginia Pomar i, Belén Aracil j, Nieves Larrosa d, Jesús Agüero e, k, Antonio Oliver f, Ana Fernández g, Jesús Oteo j, Alvaro Pascual a, h, Ferran Navarro c
Corresponding author. Unidad Clínica de Enfermedades Infecciosas y Microbiología, Enfermedades Infecciosas, Hospital Universitario Virgen Macarena, Avda Dr Fedriani 3, 41009 Sevilla, Spain. Tel./fax: +34 955009024.Summary |
Objectives |
To investigate the epidemiology and clinical features of infections caused by Enterobacteria producing plasmid-mediated AmpC β-lactamases (pAmpC), which are emerging as a cause of resistance to extended-spectrum cephalosporins.
Methods |
A prospective multicentre cohort of patients with infection/colonisation due to pAmpC-producing Enterobacteriaceae was performed in 7 Spanish hospitals from February throughout July 2009. pAmpCs were characterised by PCR and sequencing.
Results |
140 patients were included; organisms isolated were Escherichia coli (n = 100), Proteus mirabilis (n = 20), Klebsiella pneumoniae (n = 17), and others (n = 3). Overall, 90% had a chronic underlying condition. The acquisition was nosocomial in 43%, healthcare-associated in 41% (14% of those were nursing home residents), and community in 16%. Only 5% of patients had no predisposing feature for infection with multidrug-resistant bacteria. Nineteen percent of patients were bacteraemic. Inappropriate empirical therapy was administered to 81% of bacteraemic patients, who had a crude mortality rate of 48%. The most frequent enzyme was CMY-2 (70%, predominantly in E. coli and P. mirabilis) followed by DHA-1 (19%, predominantly in K. pneumoniae).
Conclusion |
pAmpC-producing Enterobacteriaceae caused nosocomial, healthcare-associated and community infections mainly in predisposed patients. Invasive infections were associated with high mortality which might be partly related to inappropriate empirical therapy.
Le texte complet de cet article est disponible en PDF.Keywords : Plasmid-mediated AmpC, β-Lactamases, Bloodstream infections, Risk factors, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis
Plan
Vol 64 - N° 2
P. 176-183 - février 2012 Retour au numéro
Article précédent
- Orthopaedic-implant infections by Escherichia coli: Molecular and phenotypic analysis of the causative strains
- Lise Crémet, Stéphane Corvec, Pascale Bémer, Laurent Bret, Cécile Lebrun, Béatrice Lesimple, Anne-Françoise Miegeville, Alain Reynaud, Didier Lepelletier, Nathalie Caroff
- Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates
- Diego Vicente, Olatz Esnal, Emilio Pérez-Trallero
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?